At present the backbone of his treatment program is maraviroc and statins then throwing other things in the mix to see if anything sticks. Early on it was heavy on ivermectin which based on it's MOA of "anti-viral" would be useless against inert viral fragments.

Patterson says that maraviroc is as effective as leronlimab. From receptor occupancy to NKT cell production and end results that's simply not the case. Of course if leronlimab or leronlimab combined with another specific drug fixed the symptoms of longhaulers then his assays would fall by the wayside. Is it any wonder he's so eager to sell IncellDx even at a cost to his dignity.